
Albert Mark Navarro
Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 2899, 1817 |
| Total Applications | 2079 |
| Issued Applications | 1540 |
| Pending Applications | 155 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16214104
[patent_doc_number] => 10729897
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Systems and methods for delivery of a therapeutic agent
[patent_app_type] => utility
[patent_app_number] => 16/036381
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 28
[patent_no_of_words] => 8614
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16036381
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/036381 | Systems and methods for delivery of a therapeutic agent | Jul 15, 2018 | Issued |
Array
(
[id] => 17741430
[patent_doc_number] => 11389475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Method for inducing an M1 dominated immune response and pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 16/629642
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10580
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629642
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629642 | Method for inducing an M1 dominated immune response and pharmaceutical compositions | Jul 12, 2018 | Issued |
Array
(
[id] => 15862955
[patent_doc_number] => 20200138881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => NEW PROBIOTIC COMPOSITION FOR PREVENTION OF BACTERIAL VAGINOSIS
[patent_app_type] => utility
[patent_app_number] => 16/628762
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628762 | Probiotic composition for prevention of bacterial vaginosis | Jul 11, 2018 | Issued |
Array
(
[id] => 13870769
[patent_doc_number] => 20190031725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => Campylobacter Immunogenic Compositions and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/027575
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16027575
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/027575 | Campylobacter immunogenic compositions and uses thereof | Jul 4, 2018 | Issued |
Array
(
[id] => 13793297
[patent_doc_number] => 20190010187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => Polysaccharide Purification for Vaccine Production using Lytic Enzymes, Tangential Flow Filtration, and Multimode Chromatography
[patent_app_type] => utility
[patent_app_number] => 16/023425
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023425 | Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography | Jun 28, 2018 | Issued |
Array
(
[id] => 16841732
[patent_doc_number] => 11013791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => NYVAC-based plasmodium malaria vaccine
[patent_app_type] => utility
[patent_app_number] => 16/625055
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 27
[patent_no_of_words] => 20884
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625055 | NYVAC-based plasmodium malaria vaccine | Jun 21, 2018 | Issued |
Array
(
[id] => 16108509
[patent_doc_number] => 20200206277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => AMMONIA OXIDIZING MICROORGANISMS FOR DISPERSING BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 16/622427
[patent_app_country] => US
[patent_app_date] => 2018-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622427
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622427 | AMMONIA OXIDIZING MICROORGANISMS FOR DISPERSING BIOFILMS | Jun 12, 2018 | Abandoned |
Array
(
[id] => 16605970
[patent_doc_number] => 10906962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/005647
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 23810
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005647
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005647 | Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof | Jun 10, 2018 | Issued |
Array
(
[id] => 15726767
[patent_doc_number] => 10611805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Modified biotin-binding protein, fusion proteins thereof and applications
[patent_app_type] => utility
[patent_app_number] => 15/992343
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 36036
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/992343 | Modified biotin-binding protein, fusion proteins thereof and applications | May 29, 2018 | Issued |
Array
(
[id] => 13425071
[patent_doc_number] => 20180264078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => NOVEL MICROCIN AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/992874
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992874
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/992874 | Microcin and uses thereof | May 29, 2018 | Issued |
Array
(
[id] => 14210731
[patent_doc_number] => 20190117750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => COMPOSITIONS COMPRISING ANGIOGENIC FACTORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/990790
[patent_app_country] => US
[patent_app_date] => 2018-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990790
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990790 | Compositions comprising angiogenic factors and methods of use thereof | May 27, 2018 | Issued |
Array
(
[id] => 15862943
[patent_doc_number] => 20200138875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => AGENT FOR TREATING MICROBIOME-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/612517
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612517 | AGENT FOR TREATING MICROBIOME-RELATED DISEASES | May 24, 2018 | Abandoned |
Array
(
[id] => 13440849
[patent_doc_number] => 20180271967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => OUTER MEMBRANE VESICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/986955
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986955
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986955 | Outer membrane vesicles and uses thereof | May 22, 2018 | Issued |
Array
(
[id] => 16053195
[patent_doc_number] => 20200188452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => PURIFIED ANTHELMINTIC COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 16/607677
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607677 | Purified anthelmintic compositions and related methods | May 21, 2018 | Issued |
Array
(
[id] => 16924050
[patent_doc_number] => 11045506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitis
[patent_app_type] => utility
[patent_app_number] => 15/984613
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 47
[patent_no_of_words] => 13435
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984613
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984613 | Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitis | May 20, 2018 | Issued |
Array
(
[id] => 13413207
[patent_doc_number] => 20180258146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => EXPRESSION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/973715
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15973715
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/973715 | EXPRESSION SYSTEM | May 7, 2018 | Abandoned |
Array
(
[id] => 16822708
[patent_doc_number] => 20210138001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => DIAGNOSIS, PREVENTION AND TREATMENT OF DEMYELINATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/611704
[patent_app_country] => US
[patent_app_date] => 2018-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611704 | DIAGNOSIS, PREVENTION AND TREATMENT OF DEMYELINATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM | May 6, 2018 | Abandoned |
Array
(
[id] => 15135411
[patent_doc_number] => 10481166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Microparticle fractionation
[patent_app_type] => utility
[patent_app_number] => 15/970952
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12846
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/970952 | Microparticle fractionation | May 3, 2018 | Issued |
Array
(
[id] => 15553537
[patent_doc_number] => 20200061180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => DIAGNOSIS AND TREATMENT OF INFECTION INVOLVING KILLER T FOLLICULAR HELPER CELLS, METHODS OF PREPARATION, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/609784
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609784 | Diagnosis and treatment of infection involving killer t follicular helper cells, methods of preparation, and uses thereof | May 2, 2018 | Issued |
Array
(
[id] => 16381965
[patent_doc_number] => 10806776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Method of treating fungal infection
[patent_app_type] => utility
[patent_app_number] => 15/969169
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 15474
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15969169
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/969169 | Method of treating fungal infection | May 1, 2018 | Issued |